Press releases

120516 PDMR dealings.pdf (190.3 kB)

120514 PDMR dealings.pdf (190.1 kB)

120510 PDMR dealings.pdf (190.4 kB)

120508 PDMR dealings.pdf (189.9 kB)

120503 Director Shareholding.pdf (202.3 kB)

120403 Appointment of Robert Taylor.pdf (249.2 kB)

120312 Cranage Earn out settlement.pdf (48.2 kB)

120222 Interims announcement.pdf (673.8 kB)

120113 Trading update FR.pdf (68.8 kB)

120113 Trading update.pdf (396.2 kB)

111208 ABT acquisition announcement FR.pdf (182.9 kB)

111208 ABT acquisition announcement.pdf (325.6 kB)

111115 Mysoline disposal announcement FR.pdf (292.8 kB)

111115 Mysoline disposal announcement.pdf (288.6 kB)

111011 Fannin Ireland.pdf (285.4 kB)

110922 Prelims FY11.pdf (213.3 kB)

110922 Invida launches announcement FR.pdf (103.8 kB)

110921 Invida launches.pdf (105.3 kB)

110921 Board Changes.pdf (98.0 kB)

110831 Episil License agreement with Teva FR.pdf (103.4 kB)

110831 Episil License agreement with Teva.pdf (103.1 kB)

110804 Delmopinol option and licensing agreement FR.pdf (137.0 kB)

110804 Delmopinol option and licensing agreement.pdf (78.5 kB)

110714 Trading Update FR.pdf (109.2 kB)

110714 Trading Update.pdf (104.8 kB)

110623 Change of adviser.pdf (89.9 kB)

110610 Directorate change.pdf (63.8 kB)

110518 Interim management statement FR.pdf (118.6 kB)

110518 Interim management statement.pdf (118.0 kB)

110503 General Meeting Announcement.pdf (37.8 kB)

110407 Sinclair IS Pharma - 2 5 Announcement.pdf (164.5 kB)

110321 Invida India Announcement FR.pdf (119.7 kB)

110321 Invida India Announcement.pdf (117.2 kB)

110223 Interims results.pdf (619.2 kB)

110214 Sinclair Pharma plc and IS Pharma plc - Announcement of a Possible Merger.pdf (29.5 kB)

110110 Trading update 1H FY11.pdf (106.9 kB)

110110 Trading update 1H FY11 FR.pdf (107.7 kB)

101208 Sunstar agreement announcement FR.pdf (108.6 kB)

101208 Sunstar agreement announcement.pdf (105.3 kB)

101207 Invida Announcement FR.pdf (122.8 kB)

101207 Invida Announcement.pdf (119.8 kB)

101202 KeloCote Distribution in UK and Germany.pdf (108.0 kB)

101202 Kelo-cote Distribution in UK and Germany FR.pdf (84.8 kB)

101130 Terbinafine Spray Press Release FR.pdf (131.2 kB)

101130 Terbinafine Spray Press Release.pdf (101.9 kB)

101118 Results of Annual General Meeting.pdf (16.6 kB)

101107a Interim management statement FR.pdf (115.4 kB)

101107a Interim management statement.pdf (113.8 kB)

101012 Grant of share awards.pdf (17.7 kB)

101008 Notification of major interest in shares 2.pdf (19.2 kB)

101008 Notification of major interest in shares.pdf (18.8 kB)

101004 Result of General Meeting.pdf (18.3 kB)

101001 Results of the Firm Placing and Placing and Open Offer.pdf (19.5 kB)

100927 Notification of Major Interest in Shares.pdf (8.8 kB)

100917 Publication of Prospectus.pdf (44.9 kB)

100917 Notification of Major Interest in Shares.pdf (18.7 kB)

100913 Atopiclair Cream receives reimbursement status in France.pdf (19.8 kB)

100909 FY Results - Restructuring primes business for growth.pdf (71.7 kB)

100907 Kelo-Cote licensing deal completed.pdf (20.6 kB)

100906 Convertible Unsecured Loan Notes.pdf (17.9 kB)

100826 Proposed Firm Placing and Placing and Open Offer.pdf (36.1 kB)

100810 Block Listing Six Monthly Return.pdf (16.5 kB)

100730 Total Voting Rights.pdf (16.5 kB)

100716 Trading Update.pdf (18.9 kB)

100630 Total Voting Rights.pdf (16.5 kB)

100603 Director-PDMR Shareholding.pdf (16.6 kB)

100602 Decapinol Agreement.pdf (18.3 kB)

100528 Director-PDMR Shareholding.pdf (16.7 kB)

100525 Director-PDMR Shareholding.pdf (16.6 kB)

100519 Interim Management Statement.pdf (23.1 kB)

100505 Director-PDMR Shareholding.pdf (16.7 kB)

100429 Holding_s_ in Company.pdf (17.2 kB)

100422 Agreement with Syntopix Group plc.pdf (19.2 kB)

100413 Holding_s_ in Company.pdf (16.6 kB)

100331 Total Voting Rights.pdf (16.6 kB)

100316 Holding_s_ in Company.pdf (16.6 kB)

100225 Interim results for the six months ended 31 December 2009.pdf (61.9 kB)

100211 Notice of Results.pdf (16.7 kB)

100210 Blocklisting Interim Review.pdf (17.4 kB)

100113 Director Shareholding.pdf (17.6 kB)

091222 Result of AGM.pdf (18.0 kB)

091216 Holding_s_ in Company.pdf (21.5 kB)

091215 Total Voting Rights.pdf (17.1 kB)

091215 Holding_s_ in Company.pdf (21.3 kB)

091211 Acquisition of Flammazine and Flammacerium from Solvay.pdf (18.3 kB)

091210 Result of General Meeting.pdf (18.0 kB)

091210 Result of Firm Placing and Open Offer.pdf (19.9 kB)

091201 Holding_s_ in Company.pdf (21.4 kB)

091126 Annual Report and Notice of AGM.pdf (18.0 kB)

091126 Annual Information Update.pdf (21.9 kB)

091124 Publication of Prospectus.pdf (46.5 kB)

091123 Jerry Randall to step down as CFO.pdf (18.5 kB)

091119 Interim Management Statement.pdf (19.3 kB)

091112 Sinclair Pharma and Orapharma mutually agree to terminate US distribution agreement for Decapinol mouth rinse.pdf (19.7 kB)

091111 Result of General Meeting.pdf (17.6 kB)

091102 Annual Report.pdf (16.5 kB)

091029 New Debt Facility.pdf (17.9 kB)

091012 Preliminary results for the year ended 30 June 2009.pdf (69.8 kB)

091012 Acquisition of Flammazine and Flammacerium from Solvay.pdf (23.2 kB)

091005 Convertible Unsecured Loan Note.pdf (17.9 kB)

090923 Re-convertible Unsecured Loan Note.pdf (17.9 kB)

090923 DJ INVESCO Limited Rule 8.pdf (18.7 kB)

090922 Share Price Movement.pdf (17.3 kB)

090914 Second Price Monitoring Extension.pdf (16.5 kB)

090914 Price Monitoring Extension.pdf (16.5 kB)

090907 Placement of Convertible Unsecured Loan Notes.pdf (18.4 kB)

090828 Total Voting Rights.pdf (17.1 kB)

090817 Blocklisting Interim Review.pdf (17.4 kB)

090804 Sebclair launched in the US2.pdf (21.5 kB)

090804 Sebclair launched in the US.pdf (21.5 kB)

090722 Trading update for the year ending 30 June 2009.pdf (19.3 kB)

090615 Holding_s_ in Company.pdf (16.3 kB)

090422 Change of Adviser and Stockbroker.pdf (17.0 kB)

090318 Second Price Monitoring Extension.pdf (16.3 kB)

090318 Price Monitoring Extension.pdf (16.3 kB)

090318 Interim Management Statement.pdf (22.8 kB)

090303 Change of Adviser.pdf (16.9 kB)

090226 Interim results.pdf (54.5 kB)

090220 Agreements signed with BMG Pharma on further development of Sinclair pipeline and technologies.pdf (20.2 kB)

090213 Notice of Interim Results.pdf (7.4 kB)

090209 Blocklisting Interim Review.pdf (16.6 kB)

090205 Notification of major interests in shares.pdf (17.9 kB)

090204 Sinclair strengthens its European sales and marketing operations and further expands its export network with 19 new agreements.pdf (22.7 kB)

090123 Notification of major interests in shares.pdf (18.1 kB)

090107 Agreement signed with Graceway for Atopiclair in the US.pdf (18.8 kB)

081231 Total Voting Rights.pdf (16.7 kB)

081222 Sales collaboration with York Pharma.pdf (18.5 kB)

081212 Directors' Share Dealing.pdf (17.8 kB)

081211 Grant of Share Awards under Long-term Incentive Plan.pdf (17.9 kB)

081208 Placing.pdf (17.2 kB)

081208 AGM Statement.pdf (21.7 kB)

081128 Total Voting rights.pdf (16.7 kB)

081120 Annual Information Update.pdf (21.2 kB)

081118 Additional Listing.pdf (17.2 kB)

081114 Additional Listing.pdf (17.8 kB)

081111 Interim Management Statement.pdf (21.9 kB)

081111 2008 Annual Report and Accounts.pdf (17.2 kB)

081105 Appointment of Vice President of Business Development.pdf (18.3 kB)

081104 Correction 2008 Annual Report and Accounts.pdf (17.1 kB)

081103 Sinclair Pharma's Non-Executive Chairman.pdf (19.0 kB)

081103 2008 Annual Report and Accounts.pdf (17.1 kB)

081031 Total Voting Rights.pdf (16.7 kB)

081031 Statement re Funding Update.pdf (17.9 kB)

081031 Second Price Monitoring Extension.pdf (16.3 kB)

081031 Price Monitoring Extension.pdf (16.3 kB)

081022 Update on Strategic Opportunity.pdf (16.7 kB)

IS Pharma press releases

110504 John Gregory Dealing Disclosure following exercise of options.pdf (36.6 kB)

110504 Issue of Shares to John Gregory.pdf (15.8 kB)

110216 Public Opening Position Disclosure by a Party to an Offer.pdf (35.6 kB)

110214 Sinclair Pharma plc and IS Pharma plc - Announcement of a Possible Merger.pdf (90.7 kB)

110107 IS Pharma and Helsinn Healthcare Announce Strategic Alliance.pdf (103.9 kB)

101207 TR-1 Notification of Major Interest in Shares.pdf (18.3 kB)

101206 TR-1 Notification of Major Interest in Shares 3.pdf (46.9 kB)

101206 TR-1 Notification of Major Interest in Shares 2.pdf (21.3 kB)

101206 TR-1 Notification of Major Interest in Shares.pdf (22.6 kB)

101202 Holding(s) in Company 02 December 2010.pdf (31.2 kB)

101129 Result of General Meeting on 29 November 2010.pdf (49.7 kB)

101129 Grant of Options 29 November 2010.pdf (67.4 kB)

101111 Posting of Circular Announcement on 11 November 2010.pdf (45.4 kB)

101110 £12.5 million Cash Placing.pdf (18.3 kB)

101110 Interim Results for the six months ended 30 September 2010.pdf (118.2 kB)

101103 TR-1 Notification of Major Interest in Shares.pdf (62.3 kB)

101006 £3.6 million Cash Placing at 9% Premium and Maiden Dividend.pdf (52.1 kB)

100917 Mouth Cancer Awareness Walk.pdf (56.8 kB)

100909 UK Launch of Aquoral.pdf (52.8 kB)

100727 Result of AGM.pdf (60.1 kB)

100727 AGM Statement.pdf (67.2 kB)

100702 Posting of Annual Report and Notice of AGM.pdf (68.2 kB)

100602 Preliminary Results.pdf (822.9 kB)

100419 Close Period Trading Update.pdf (9.3 kB)

100322 Sale of Volplex and Isoplex.pdf (70.6 kB)

100304 IS Pharma acquires exclusive European rights for Episil®.pdf (30.7 kB)

100111 IS Pharma granted exclusive license and supply rights for Aequasyal® (oxidised glycerol triester) in the UK.pdf (41.7 kB)